Second-line chemotherapy for advanced biliary tract cancer after failure of the gemcitabine-platinum combination: A large multicenter study by the Association des Gastro-Entérologues Oncologues-Reference-Cited by-同舟云学术

Second-line chemotherapy for advanced biliary tract cancer after failure of the gemcitabine-platinum combination: A large multicenter study by the Association des Gastro-Entérologues Oncologues

Published:2015-06-05 Issue:18 Volume:121 Page:3290-3297
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Brieau Bertrand¹,Dahan Laetitia²³,De Rycke Yann⁴,Boussaha Tarek⁵,Vasseur Philippe⁶⁷,Tougeron David⁶⁷,Lecomte Thierry⁸⁹,Coriat Romain¹¹⁰,Bachet Jean-Baptiste¹¹¹²,Claudez Pierre¹³,Zaanan Aziz¹⁴¹⁵,Soibinet Pauline¹⁶,Desrame Jérome¹⁷,Thirot-Bidault Anne¹⁸,Trouilloud Isabelle¹⁹,Mary Florence²⁰,Marthey Lysiane²¹,Taieb Julien¹⁴¹⁵,Cacheux Wulfran²²,Lièvre Astrid²³²⁴

Affiliation:

1. Gastroenterology and Digestive Oncology Unit; Cochin Teaching Hospital; Paris France

2. Digestive Oncology Unit; La Timone Hospital; Marseille France

3. Faculty of Medicine-Timone; Aix-Marseille University; Marseille France

4. Public Health Department; Curie Institute; Paris France

5. Gastroenterology Unit; Saint Antoine Hospital; Paris France

6. Gastroenterology Unit; Poitiers Teaching Hospital; Poitiers France

7. Laboratory of Inflammation, Epithelial Tissues, and Cytokines (EA 4331); Poitiers University; Poitiers France

8. Gastroenterology Unit; Tours Teaching Hospital; Tours France

9. Faculty of Medicine; Francois Rabelais University; Tours France

10. Cochin-Port Royal Faculty of Medicine; Paris Descartes University; Paris France

11. Gastroenterology Unit; La Pitié Salpêtrière Hospital; Paris France

12. Faculty of Medicine; Pierre and Marie Curie University; Paris France

13. Gastroenterology and Hepatology Unit, Saint Etienne Teaching Hospital; North Hospital; Saint-Priest-en-Jarez France

14. Gastroenterology and Digestive Unit; Georges Pompidou European Hospital; Paris France

15. Paris Descartes University-Sorbonne Paris Cité; Paris France

16. Gastroenterology Unit; Reims Teaching Hospital; Reims France

17. Gastroenterology Unit; Jean Mermoz Hospital; Lyon France

18. Gastroenterology Unit; Kremlin-Bicêtre Hospital; Le Kremlin-Bicêtre France

19. Gastroenterology Unit; Amboise Paré Hospital; Boulogne-Billancourt France

20. Gastroenterology Unit; Avicenne Hospital; Bobigny France

21. Gastroenterology Unit; Antoine Béclère Hospital; Clamart France

22. Department of Medical Oncology; Curie Institute Hospital; Paris France

23. Department of Medical Oncology, René Huguenin Hospital; Curie Institute; Saint-Cloud France

24. Faculty of Health Sciences; Versailles Saint-Quentin-en-Yvelines University; Montigny-Le-Bretonneux France

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference34 articles.

1. Cancer statistics, 2014;Siegel;CA Cancer J Clin.,2014

2. Diagnosis and treatment of cholangiocarcinoma;Anderson;Oncologist.,2004

3. Biliary tract cancers;Groen;N Engl J Med.,1999

4. Best supportive care compared with chemotherapy for unresectable gall bladder cancer: a randomized controlled study;Sharma;J Clin Oncol.,2010

5. Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer;Glimelius;Ann Oncol.,1996

Cited by 97 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Second-Line Chemotherapy for Intrahepatic Cholangiocarcinomas: What Is the Real Gain?;Life;2023-11-06

2. A Systematised Literature Review of Real-World Treatment Patterns and Outcomes in Unresectable Advanced or Metastatic Biliary Tract Cancer;Targeted Oncology;2023-09-26

3. Comparison between regular additional endobiliary radiofrequency ablation and photodynamic therapy in patients with advanced extrahepatic cholangiocarcinoma under systemic chemotherapy;Frontiers in Oncology;2023-08-29

4. Study protocol of an open-label, single arm phase II trial investigating the efficacy and safety of Trifluridine/Tipiracil combined with irinotecan as a second line therapy in patients with cholangiocarcinoma (TRITICC);BMC Cancer;2023-05-22

5. Multidisciplinary Treatment of Patients with Progressive Biliary Tract Cancer after First-Line Gemcitabine and Cisplatin: A Single-Center Experience;Cancers;2023-05-03